Press Releases / Recent News

28th February 2017

Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer

  • Press release here

20th January 2017

The CRT Pioneer Fund and Cancer Research UK’s Manchester Institute nominate cancer drug candidate

  • Press release here

6th October 2016

CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration

  • Press release here

21 November 2014

CRT Pioneer Fund announces investment to develop lung cancer drugs at Cancer Research UK’s Manchester Institute

  • Press release here

29 November 2013

CRT, University of Manchester and GlaxoSmithKline Work Together to Generate New Cancer Drugs

  • Collaboration to create potential new drugs which target a key protein involved in epigenetic regulation
  • Press release here

8 November 2013

HitGen Announces Collaboration in Drug Discovery with the University of Manchester’s Cancer Research UK Manchester Institute and Cancer Research Technology

  • Partnership will use HitGen’s DNA Encoded Library Technology for Drug Lead Identification
  • BioCentury article here

14 June 2013

CRT, University of Manchesterand AstraZeneca Work Together toSeek New Cancer Drugs

  • Collaboration to discover and developcompounds in area of DNA damage repair
  • Groundbreaking access to screen AZ compound collection agains tadditional targets of mutual interest
  • BioCentury article here